JenniferAWrightMD
Pediatric Hematology & Oncology • Salt Lake City, UTAssistant Professor, Pediatrics, University of Utah School of Medicine
Are you Dr. Wright?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 34 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
100 Mario Capecchi Dr
Salt Lake City, UT 84113Phone+1 801-662-4700- Is this information wrong?
Summary
- Dr. Jennifer Wright, MD is a pediatric hematologist/oncologist in Salt Lake City, Utah. She is currently licensed to practice medicine in Utah and Indiana. She is affiliated with University of Utah Health and is an Assistant Professor at University of Utah School of Medicine.
Education & Training
University of Texas Southwestern Medical CenterFellowship, Pediatric Hematology/Oncology, 2004 - 2007
Indiana University School of MedicineResidency, Internal Medicine/Pediatrics, 2000 - 2004- Indiana University School of MedicineClass of 2000
Certifications & Licensure
IN State Medical License 2002 - 2023
UT State Medical License 2007 - 2018
Clinical Trials
- Metformin in Children With Relapsed or Refractory Solid Tumors Start of enrollment: 2012 Sep 24
- Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma Start of enrollment: 2012 Aug 01
- Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies Start of enrollment: 2013 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 7 citationsA phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results.Steven Attia, Vanessa Bolejack, Kristen N Ganjoo, Suzanne George, Mark Agulnik, Daniel Rushing, Elizabeth T Loggers, Michael B Livingston, Jennifer Wright, Sant P Chaw...> ;Cancer Medicine. 2023 Jan 1
- 99 citationsTumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2,...Vivek Subbiah, Jürgen Wolf, Bhavana Konda, Hyunseok Kang, Alexander Spira, Jared Weiss, Masayuki Takeda, Yuichiro Ohe, Saad Khan, Kadoaki Ohashi, Victoria Soldatenkova...> ;The Lancet. Oncology. 2022 Oct 1
- 18 citationsProspective Evaluation of Doxorubicin Cardiotoxicity in Patients with Advanced Soft-tissue Sarcoma Treated in the ANNOUNCE Phase III Randomized Trial.Robin L. Jones, Andrew J. Wagner, Akira Kawai, Kazuo Tamura, Ashwin Shahir, Brian A. Van Tine, Javier Martin-Broto, Patrick Peterson, Jennifer Wright, William D. Tap> ;Clinical Cancer Research. 2021 Feb 25
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
University of Utah HealthSalt Lake City, Utah
UW Medicine/University of Washington Medical CenterSeattle, Washington
